Resources
Blog Posts
Koneksa is at the forefront of digital biomarker discovery and testing, and our science-based understanding of their capabilities across therapeutic areas gives us a unique perspective. We are proud to share our insights, and we welcome your inquiries. Explore our articles to gain insights into the potential of digital biomarkers in clinical research.
Found 59 Results
Page 1 of 10
Article
Innovation in Biometrics:
What AI, ICH E6(R3) and Continuous Data Mean for Clinical Data Management
Every trial result rests on biometrics: the clinical data management, biostatistics and statistical programming work that turns raw trial data into decision-ready evidence. That work is changing faster than it... Download
Article
Digital Biomarkers vs. Traditional Biomarkers: A Complete Comparison
As consumer technology continues to advance, wearable or portable smart devices are becoming increasingly accessible, contributing to the rapid emergence of digital biomarkers in modern healthcare, as well as a... Download
Article
The Complete Guide to the Finger Tap Test: What It Measures, How It Is Used, and Why Digital Approaches Are Changing What It Can Reveal
The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a... Download
Article
What Are Digital Biomarkers?
Healthcare systems worldwide are increasingly shifting toward data-driven models integrated with digital health technologies (DHTs) and artificial intelligence (AI). This shift is reflected in the rapid growth of the global... Download
Article
What Digital Measures Are Really Capturing in Parkinson’s Disease and Why It Matters for Clinical Trials
Insights from new peer-reviewed research by Koneksa during Parkinson's Awareness Month Behind Every Dataset is a Lived Experience. In Parkinson’s disease, symptoms do not progress in neat, linear steps.... Download
Article
5 Questions to Ask Before Choosing a Digital Biomarkers Partner
Introduction The adoption of digital biomarkers in clinical trials is accelerating rapidly, driven by wearable sensors, decentralized trial models, and the demand for continuous patient monitoring. As sponsors increasingly explore... Download
